Axis Small Cap Fund

A Small Cap Fund scheme from Axis Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF846K01K35).

NAV ₹134.4700 on 16 November 2026.

Expense ratio

Total expense ratio 0.70% a year for the Direct · Growth plan, as AMFI published it on 28 October 2026: base expense ratio 0.52%, brokerage 0.03%, transaction costs 0.00%, statutory levies including GST 0.15%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year7.6%15.8%-14.5%0.040.04
3 years13.8%15.2%-19.4%0.450.42
5 years14.7%14.4%-19.4%0.540.48
10 years20.0%14.8%-34.6%0.880.77

Category rank: 11th of 27 Direct-Growth funds in Small Cap Fund, by 3-year Sortino ratio.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 90.5% of the portfolio.

  1. Clearing Corporation of India Ltd (cash (TREPS)) — 8.46%
  2. Torrent Pharmaceuticals Limited — 2.34%
  3. Krishna Institute of Medical Sciences Limited — 2.28%
  4. CCL Products (India) Limited — 2.13%
  5. Sai Life Sciences Limited — 1.97%
  6. City Union Bank Limited — 1.92%
  7. Sansera Engineering Limited — 1.77%
  8. Navin Fluorine International Limited — 1.55%
  9. Brigade Enterprises Limited — 1.48%
  10. Karur Vysya Bank Limited — 1.48%

Plans

Other funds in Small Cap Fund

All 37 funds in Small Cap Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.